ConductScience.org, home

Trial · NCT02558296

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Completed the Study Through Week 24STARTEDBexagliflozin Tablets, 20 mg1,133
Completed the Study Through Week 24STARTEDPlacebo Tablets567
Completed the Study Through Week 24COMPLETEDBexagliflozin Tablets, 20 mg1,089
Completed the Study Through Week 24COMPLETEDPlacebo Tablets542
Completed the Study Through Week 24NOT COMPLETEDBexagliflozin Tablets, 20 mg44
Completed the Study Through Week 24NOT COMPLETEDPlacebo Tablets25
Completed the StudySTARTEDBexagliflozin Tablets, 20 mg1,133
Completed the StudySTARTEDPlacebo Tablets567
Completed the StudyCOMPLETEDBexagliflozin Tablets, 20 mg987
Completed the StudyCOMPLETEDPlacebo Tablets482
Completed the StudyNOT COMPLETEDBexagliflozin Tablets, 20 mg146
Completed the StudyNOT COMPLETEDPlacebo Tablets85

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02558296/flow